Feng Y - Search Results

1

Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist.

Lv M, Yu J, Chen P, Xiao Q, Lou L, Luo Y, Yuan M, Xu Y, Feng Y, Bai M, Zhang Z, Li L. Lv M, et al. Among authors: feng y. Front Endocrinol (Lausanne). 2022 Oct 7;13:1037220. doi: 10.3389/fendo.2022.1037220. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36277710 Free PMC article.

2

Overexpression of follicle-stimulating hormone receptor facilitates the development of ovarian epithelial cancer.

Zhang Z, Jia L, Feng Y, Zheng W. Zhang Z, et al. Among authors: feng y. Cancer Lett. 2009 Jun 8;278(1):56-64. doi: 10.1016/j.canlet.2008.12.024. Epub 2009 Jan 31. Cancer Lett. 2009. PMID: 19181441

3

Aberrant survivin expression in endometrial hyperplasia: another mechanism of progestin resistance.

Chen X, Zhang Z, Feng Y, Fadare O, Wang J, Ai Z, Jin H, Gu C, Zheng W. Chen X, et al. Among authors: feng y. Mod Pathol. 2009 May;22(5):699-708. doi: 10.1038/modpathol.2009.25. Epub 2009 Mar 13. Mod Pathol. 2009. PMID: 19287462 Free article.

4

[Expression of glyoxalase I and its effect on cell proliferation and apoptosis in endometrial carcinoma].

Sui L, Guo QS, Zhang ZB, Jin HY, Yu YH, Feng YJ. Sui L, et al. Zhonghua Fu Chan Ke Za Zhi. 2010 Jun;45(6):429-33. Zhonghua Fu Chan Ke Za Zhi. 2010. PMID: 21029593 Chinese.

5

Luteinizing hormone upregulates survivin and inhibits apoptosis in ovarian epithelial tumors.

Zhang Z, Liao H, Chen X, Zheng Y, Liu Y, Tao X, Gu C, Dong L, Duan T, Yang Y, Liu X, Yu Y, Feng Y. Zhang Z, et al. Among authors: feng y. Eur J Obstet Gynecol Reprod Biol. 2011 Mar;155(1):69-74. doi: 10.1016/j.ejogrb.2010.10.017. Epub 2010 Nov 11. Eur J Obstet Gynecol Reprod Biol. 2011. PMID: 21074309

6

Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer.

Gu C, Zhang Z, Yu Y, Liu Y, Zhao F, Yin L, Feng Y, Chen X. Gu C, et al. Among authors: feng y. Cancer Sci. 2011 Mar;102(3):557-64. doi: 10.1111/j.1349-7006.2010.01829.x. Epub 2011 Jan 18. Cancer Sci. 2011. PMID: 21205080 Free PMC article.

7

Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression.

Zhang Z, Dong L, Sui L, Yang Y, Liu X, Yu Y, Zhu Y, Feng Y. Zhang Z, et al. Among authors: feng y. Int J Gynecol Cancer. 2011 Feb;21(2):213-21. doi: 10.1097/IGC.0b013e318207dac7. Int J Gynecol Cancer. 2011. PMID: 21270604

8

Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.

Wei Y, Zhang Z, Liao H, Wu L, Wu X, Zhou D, Xi X, Zhu Y, Feng Y. Wei Y, et al. Among authors: feng y. Oncol Rep. 2012 Feb;27(2):504-10. doi: 10.3892/or.2011.1536. Epub 2011 Nov 8. Oncol Rep. 2012. PMID: 22075757

9

NRF2 is overexpressed in ovarian epithelial carcinoma and is regulated by gonadotrophin and sex-steroid hormones.

Liao H, Zhou Q, Zhang Z, Wang Q, Sun Y, Yi X, Feng Y. Liao H, et al. Among authors: feng y. Oncol Rep. 2012 Jun;27(6):1918-24. doi: 10.3892/or.2012.1700. Epub 2012 Feb 28. Oncol Rep. 2012. PMID: 22378150

10

Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation via the PTEN/PI3K/AKT signaling pathway.

Zhang J, Yang Y, Zhang Z, He Y, Liu Z, Yu Y, Wu S, Cai B, Feng Y. Zhang J, et al. Among authors: feng y. Cancer Lett. 2013 Oct 10;339(2):279-87. doi: 10.1016/j.canlet.2012.10.037. Epub 2012 Nov 8. Cancer Lett. 2013. PMID: 23142288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,797 results

Search Page

Filters